Your browser doesn't support javascript.
loading
Corrigendum to "Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer" [Biomaterials 195 (2019) 86-99].
Zhou, Ping; Qin, Jiaqi; Zhou, Ce; Wan, Guoyun; Liu, Yuanyuan; Zhang, Mingming; Yang, Xiaoying; Zhang, Ning; Wang, Yinsong.
Afiliación
  • Zhou P; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
  • Qin J; School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Basic Medical Science, Tianjin Medical University, Tianjin, 300070, China.
  • Zhou C; School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Basic Medical Science, Tianjin Medical University, Tianjin, 300070, China.
  • Wan G; School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Basic Medical Science, Tianjin Medical University, Tianjin, 300070, China.
  • Liu Y; School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Basic Medical Science, Tianjin Medical University, Tianjin, 300070, China.
  • Zhang M; Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Yang X; School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Basic Medical Science, Tianjin Medical University, Tianjin, 300070, China.
  • Zhang N; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. Electronic address: zhangning@tmu.edu.cn.
  • Wang Y; School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Basic Medical Science, Tianjin Medical University, Tianjin, 300070, China. Electronic address: wangyinsong@tmu.edu.cn.
Biomaterials ; 280: 121294, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34861511
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomaterials Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomaterials Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos